
Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc.(ANEB)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
aneb · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$6.00
+1565.7% upside
Low
$6.00
Median: $6 · Last Close: $0.36
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.34 | ↓ 5.00% |
1-day model range: $0.33–$0.35. Peak: $0.35 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ANEB · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-07-23 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2025-05-15 | Maxim Group | Maintains | Buy→Buy |
| 2024-11-19 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2024-10-01 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2023-10-03 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2023-09-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-18 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2023-05-18 | Benchmark | Maintains | Speculative Buy→Buy |
| 2023-02-14 | Benchmark | Maintains | Speculative Buy→Speculative Buy |
| 2022-07-27 | Ladenburg Thalmann | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Anebulo Pharmaceuticals, Inc. (ANEB) stock. Of the recent 11 rating actions, 0 were upgrades and 1 were downgrades. 4 analysts currently cover ANEB.
分析师推荐趋势
ANEB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$17M
EPS This Year
$-0.28
EPS Next Year
$-0.48
↑ 68.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ANEB EPS of $-0.28 for the current fiscal year, based on estimates from 1 analysts. The ANEB revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ANEB 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ANEB 的共识目标价为 $6.00(+1565.7% 上行空间),分析师共识为 Buy。
ANEB 的短期预测(明日)为 $0.34(-5.00%)。
Anebulo Pharmaceuticals, Inc. 在 OTC 上市,代码 ANEB。ANEB 在 2027 年的整体展望偏积极,在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
ANEB 预测 · 8 个问题根据 4 位华尔街分析师,ANEB 的 12 个月平均目标价为 $6.00,最高 $6.00、最低 $6.00。若有图表,中位目标价可在上方查看。相对当前价 $0.36,隐含约 +1565.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.